Join
Live feed
·
INSIDERFilingvia Quantisnow
CRISPR Therapeutics AG logo

Chief Medical Officer Patel Naimish converted options into 10,000 shares and sold $210,577 worth of shares (3,786 units at $55.62), increasing direct ownership by 47% to 19,357 units (SEC Form 4) (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRSP (CRISPR Therapeutics AG) and more on Quantisnow.